Macular Edema clinical trials at UCSD
1 in progress, 1 open to new patients
Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO
open to eligible people ages 18 years and up
This is a Phase 3, multicenter, randomized, masked, controlled, parallel group study of 12 months duration in treatment naïve subjects with RVO.
La Jolla, California and other locations